/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders...
These stocks to buy have a stable business outlook and robust free cash flows. They can create value through dividends and repurchases.
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage...
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage...
The biotech's shares rode the wave of buyout speculation higher last month.
This deal checks off several boxes for Pfizer.
Investors and analysts say there is plenty of value to find in the sector.
This under-the-radar immunotherapy maker would bring a lot to the table for Pfizer.
The stock market hit new highs while Fed chief Jerome Powell backed a bond taper.
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
With health care giants like Pfizer firing on all cylinders, these health care stocks could be in the spotlight now.
Pfizer, Moderna, Nvidia and Alibaba were our top stock trades for Tuesday. Now, let's get a look at the charts as the market hits new highs.